
Prostate adenocarcinoma (PRAD) has become one of the most prevalent malignancies in men worldwide. Although advances in diagnostic techniques and targeted therapies have improved clinical outcomes, a significant subset of patients still develops aggressive, metastatic disease with limited treatment options. At present, identifying reliable biomarkers for early risk stratification remains a critical unmet need in prostate cancer research. This study presents a dependency-informed prognostic prioritization approach by integrating multi-omics data to enhance clinical risk stratification in prostate adenocarcinoma (PRAD). Integrated analysis of CRISPR-Cas9 dependency screens and bulk RNA sequencing data prioritized tumor-dependent genes associated with PRAD cell viability. Pathway enrichment analysis indicated the involvement of these candidate genes in cell cycle regulation and tumor progression. Subsequently, an 11-gene prognostic signature was constructed via LASSO regression, effectively stratifying patients, with the high-risk cohort demonstrating significantly reduced Progression-Free Interval (PFI; log-rank p < 0.001). Among the prioritized hub genes, CDC45 exhibited marked upregulation in tumor tissues, which was confirmed by Western blotting and qRT-PCR. Collectively, this study provides a dependency-informed prognostic framework for PRAD and nominates CDC45 as a candidate prognostic biomarker, laying the groundwork for future mechanistically resolved investigations.
To investigate whether electroacupuncture (EA) at the Front-Mu acupoint group improves stress urinary incontinence (SUI) in rats through modulation of the Nrf2-mediated antioxidant pathway. Sixty-five female SD rats were randomized into sham (n = 10) and SUI model (n = 55) groups. SUI was induced by vaginal dilation and bilateral ovariectomy. Successfully modeled rats were randomly divided into model, DMSO, EA, ATRA (Nrf2 inhibitor), and EA + ATRA groups (n = 10 each). EA was applied at Zhongji (CV3), Guanyuan (CV4), and bilateral Dahe (KI12) once daily for three days. Urodynamic parameters (MBC, ALPP), antioxidant enzymes (SOD, CAT, GSH-Px), oxidative stress markers (8-OHdG, 4-HNE), apoptosis (TUNEL, Bax/Bcl-2, cleaved caspase-3), and Keap1/Nrf2 mRNA and protein expression were assessed. EA significantly increased MBC and ALPP, enhanced SOD, CAT, and GSH-Px activities, and decreased 8-hydroxy-2′-deoxyguanosine (8-OHdG) and 4-hydroxynonenal (4-HNE) levels (all P < 0.05). EA also reduced the apoptotic index, Bax/Bcl-2 ratio, and cleaved caspase-3 expression (all P < 0.05). Furthermore, EA upregulated Keap1 and Nrf2 mRNA and protein expression (all P < 0.05). These protective effects were partially abrogated by ATRA co-treatment. EA at the Front-Mu acupoint group alleviates SUI, associated with modulation of the Nrf2-mediated antioxidant pathway, enhancing antioxidant defense and inhibiting apoptosis. These findings provide preliminary mechanistic support for further investigation of electroacupuncture in SUI treatment.
Myocardial infarction (MI) is a major cause of heart failure characterized by cardiomyocyte loss, adverse remodeling, and oxidative stress, with limited effective therapeutic targets. Fibroblast growth factor 13 (FGF13), an intracellular FGF family member, has not been fully explored in MI. Integrated transcriptomic analyses, including single-cell and bulk RNA sequencing datasets, revealed that FGF13 is predominantly expressed in cardiomyocytes and is downregulated following MI. In an MI model with AAV-mediated FGF13 overexpression, FGF13 improved cardiac function, as evidenced by increased ejection fraction and fractional shortening, reduced ventricular dilation, and attenuated fibrosis and apoptosis in vivo. In vitro, hypoxia decreased FGF13 expression in a time-dependent manner, accompanied by increased reactive oxygen species (ROS) and activation of NF-κB signaling. FGF13 overexpression reduced ROS accumulation, suppressed p65 phosphorylation, and restored SOD2 expression. Moreover, TNF-α-induced NF-κB activation promoted oxidative stress, whereas FGF13 partially reversed these effects. Collectively, FGF13 alleviates MI-induced cardiac injury and adverse remodeling, accompanied by reduced oxidative stress and NF-κB activation, highlighting its potential role in the response to ischemic cardiac injury.
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Circ_0070354 has been reported to be upregulated in NSCLC tissues. However, its functional effects and regulatory mechanisms remain unclear. To address this, we employed the CCK-8, wound healing, transwell assays and xenograft models to evaluate its biological effects. The ferroptosis situation was evaluated by detecting ROS, Fe2+, MDA and GPX levels. GPX4 expression was assessed via western blot. Bioinformatics analysis and dual-luciferase reporter assay were used to explore the molecular mechanisms. The results demonstrated that circ_0070354 was significantly increased in NSCLC cells and tissues. Its knockdown inhibited cell viability, migration, invasion, and tumor growth, while promoting ferroptosis-associated changes. Further investigation revealed that circ_0070354 inhibited ferroptosis-associated changes through the miR-1231/GPX4 axis. Furthermore, circ_0070354 levels were negatively correlated with miR-1231 levels in clinical samples. In conclusion, the circ_0070354/miR-1231/GPX4 axis inhibits ferroptosis-related oxidative changes and promotes NSCLC progression, suggesting its potential as a therapeutic target.
Alzheimer's disease (AD) is a multifactorial disease, resulting from a combination of environmental and genetic predisposing factors, leading to the build-up of Amyloid (A beta) plaques and tangles of phosphorylated Tau (p-Tau). MicroRNAs such as Let-7 s have been shown to exert neurotoxic effects. MiR-107 endogenously suppresses Let-7 s, and it was found to be downregulated in the brains of AD patients. However, miR-107 expression in the hippocampus in the STZ-induced sAD model has yet to be investigated. Thus, the current study aimed to investigate the levels of selected Let-7 s and miR-107 in the acute and chronic phases of STZ-induced sAD in rats. Adult Sprague-Dawley rats were subdivided into 6 groups: young intact, young vehicle control (CSF), acute STZ, old intact, old CSF, and chronic STZ. sAD was induced by stereotaxic injection of STZ in the lateral ventricles. The acute STZ group and age-matched controls were tested 4 weeks after STZ injection, while the chronic STZ group and age-matched controls were tested 13 weeks after the injection. Results showed reductions in cognitive and locomotor activities along with increased anxiety-related behaviors in the STZ-model groups in the open-field tests and T-maze tests. P-Tau was elevated in the STZ groups and old controls, with the chronic STZ group having the highest concentration. Let-7 miRNAs did not exhibit any change in expression in any group, while miR-107 was upregulated in the STZ-model groups. There was a negative correlation between miR-107 fold change and the behavioral changes and positive correlation between miR-107 fold change and anxiety-related behaviors. Histopathological examination revealed AD-like neurodegenerative changes in the hippocampi of STZ-model rats. These results further confirm the evidence implicating miR-107 expression in AD pathogenesis.